Thomas Klueter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Thomas Klueter has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Clinton Ofoedu
3 shared publicationsAnindya Ghosh
Tilburg University Tilburg Netherlands
2 shared publicationsFelipe Monteiro
INSEAD, Fontainebleau
2 shared publicationsSolon Moreira
2 shared publicationsJaideep Anand
The Ohio State University
1 shared publicationJason T. Sigler
University of North Florida
1 shared publication
Latest Publications
- 29 October 2026
- Published by Universidad de Navarra in IESE Insight
- Vol. 170
Has adquirido una tecnología. ¿Y ahora qué?
Licenciar, retener o vender: tu decisión tras adquirir una tecnología marcará si se convierte en una ventaja competitiva o una oportunidad perdida.
- 29 October 2026
- Published by Universidad de Navarra in IESE Insight
- Vol. 170
Has adquirido una tecnología. ¿Y ahora qué?
Licenciar, retener o vender: tu decisión tras adquirir una tecnología marcará si se convierte en una ventaja competitiva o una oportunidad perdida.
- 29 October 2026
- Published by Universidad de Navarra in IESE Insight
- Vol. 170
From acquisition to advantage the power of tech licensing
Acquiring technology is only the beginning. Here are the keys to deciding whether to license it out, retain it or divest.
- 29 October 2026
- Published by Universidad de Navarra in IESE Insight
- Vol. 170
From acquisition to advantage the power of tech licensing
Acquiring technology is only the beginning. Here are the keys to deciding whether to license it out, retain it or divest.
- Open Access
- 24 August 2026
- Published by Wiley in Journal of Management Studies
The Role of Rivals in Resource Picking from Factor Markets
While we know that rivals' activities in product markets are an important source of information, we know little about how firms set expectations and react to information emerging from competitors in strategic factor markets. Our theoretical framework examines this question and explains how rivals' actions in factor markets shape a firm's own resource‐picking decisions. We consider that rivals can utilize a factor of production for different applications and distinguish three distinct rival actions that lead to strategic responses, which are explained by the mechanism of herding. Further, we consider that rivals' actions beyond information also convey competitive pressure that firms react to. We show that considering both informational and competitive cues determines whether firms respond by picking resources from factor markets or by building internal capabilities. The theoretical framework, hence, helps understand the role of rivals when firms decide to pursue new strategic factors and how they obtain such factors. We test our predictions using a fine‐grained dataset of new product development of global bio‐pharmaceutical firms from 1993 to 2018. Overall, the paper provides an important step towards a better understanding of how rivals shape firms' expectations in strategic factor markets.
- 24 August 2026
- Published by Wiley in Journal of Management Studies
Open AccessThe Role of Rivals in Resource Picking from Factor Markets
While we know that rivals' activities in product markets are an important source of information, we know little about how firms set expectations and react to information emerging from competitors in strategic factor markets. Our theoretical framework examines this question and explains how rivals' actions in factor markets shape a firm's own resource‐picking decisions. We consider that rivals can utilize a factor of production for different applications and distinguish three distinct rival actions that lead to strategic responses, which are explained by the mechanism of herding. Further, we consider that rivals' actions beyond information also convey competitive pressure that firms react to. We show that considering both informational and competitive cues determines whether firms respond by picking resources from factor markets or by building internal capabilities. The theoretical framework, hence, helps understand the role of rivals when firms decide to pursue new strategic factors and how they obtain such factors. We test our predictions using a fine‐grained dataset of new product development of global bio‐pharmaceutical firms from 1993 to 2018. Overall, the paper provides an important step towards a better understanding of how rivals shape firms' expectations in strategic factor markets.
- Open Access
- 16 October 2024
- Published by Wiley in Strategic Management Journal
- Vol. 46 (2) , 275-308
Not in‐sourced here! When does external technology sourcing yield familiar versus novel solutions?
Research Summary: When established firms source technology from specialized technology firms, extant research has typically assumed that this in‐sourced technology is novel . We test this assumption by modeling in‐sourcing decisions using a problem‐solution lens wherein firms choose from available external technological solutions to solve their market problems. Since the locus of identification, evaluation, and selection of external solutions remains internal to the firm's R&D personnel, we argue that they frequently prefer familiar over novel solutions. We identify two factors that help firms overcome this preference for familiarity: when top managers focus their attention on the market problem or when they receive feedback from unexpected failures to solve that problem. Our case control analysis of 715 in‐sourced emerging technological solutions in the biopharmaceutical industry offers broad support to our theoretical framework. Managerial Summary: Established firms are commonly advised to source novel technologies externally. Yet since this sourcing process is driven by in‐house R&D personnel, we suggest that a firm's choice of external technology solutions may still tend toward familiar ones. We confirm this preference by examining in‐sourcing events of emerging technological solutions by established firms in the biopharmaceutical industry. Despite this preference, we then show that increased top management attention toward a market problem and experiencing unexpected failures in bringing products to market catalyze a receptiveness to novel technological solutions. Our findings help managers in established firms recognize that their claims or intentions to seek novel technology are not always consistent with actual in‐sourcing choices, and suggest when firms can overcome this tendency.
- 16 October 2024
- Published by Wiley in Strategic Management Journal
- Vol. 46 (2) , 275-308
Open AccessNot in‐sourced here! When does external technology sourcing yield familiar versus novel solutions?
Research Summary: When established firms source technology from specialized technology firms, extant research has typically assumed that this in‐sourced technology is novel . We test this assumption by modeling in‐sourcing decisions using a problem‐solution lens wherein firms choose from available external technological solutions to solve their market problems. Since the locus of identification, evaluation, and selection of external solutions remains internal to the firm's R&D personnel, we argue that they frequently prefer familiar over novel solutions. We identify two factors that help firms overcome this preference for familiarity: when top managers focus their attention on the market problem or when they receive feedback from unexpected failures to solve that problem. Our case control analysis of 715 in‐sourced emerging technological solutions in the biopharmaceutical industry offers broad support to our theoretical framework. Managerial Summary: Established firms are commonly advised to source novel technologies externally. Yet since this sourcing process is driven by in‐house R&D personnel, we suggest that a firm's choice of external technology solutions may still tend toward familiar ones. We confirm this preference by examining in‐sourcing events of emerging technological solutions by established firms in the biopharmaceutical industry. Despite this preference, we then show that increased top management attention toward a market problem and experiencing unexpected failures in bringing products to market catalyze a receptiveness to novel technological solutions. Our findings help managers in established firms recognize that their claims or intentions to seek novel technology are not always consistent with actual in‐sourcing choices, and suggest when firms can overcome this tendency.
- Open Access
- 4 July 2023
- Published by Wiley in Journal of Management Studies
- Vol. 61 (5) , 2101-2136
Understanding the Link between Post‐Acquisition Resource Reconfiguration and Technology Out‐Licensing
We develop a novel framework to explain how the unique properties of out‐licensing enable R&D reconfiguration in the context of technology acquisitions. Out‐licensing is an attractive R&D strategy following acquisitions as it expands opportunities for resource reconfiguration to outside the organization by using external partners while at the same time allowing firms to continue to benefit from the technology, both financially and strategically. We also propose that the positive relationship between technology acquisitions and out‐licensing is weaker when firms cannot determine the full value potential of their R&D due to uncertainty or when they have high availability of short‐term financial slack resources. Using a sample of bio‐pharmaceutical firms, the result of a 2SLS fixed‐effect regression that accounts for the potential endogeneity of technology acquisitions provides support for our theoretical framework.
- 4 July 2023
- Published by Wiley in Journal of Management Studies
- Vol. 61 (5) , 2101-2136
Open AccessUnderstanding the Link between Post‐Acquisition Resource Reconfiguration and Technology Out‐Licensing
We develop a novel framework to explain how the unique properties of out‐licensing enable R&D reconfiguration in the context of technology acquisitions. Out‐licensing is an attractive R&D strategy following acquisitions as it expands opportunities for resource reconfiguration to outside the organization by using external partners while at the same time allowing firms to continue to benefit from the technology, both financially and strategically. We also propose that the positive relationship between technology acquisitions and out‐licensing is weaker when firms cannot determine the full value potential of their R&D due to uncertainty or when they have high availability of short‐term financial slack resources. Using a sample of bio‐pharmaceutical firms, the result of a 2SLS fixed‐effect regression that accounts for the potential endogeneity of technology acquisitions provides support for our theoretical framework.
- 18 October 2021
- Published by Wiley in Journal of Management Studies
- Vol. 59 (5) , 1315-1353
The Role of Frictions due to Top Management in Alliance Termination Decisions: Insights from Established Bio‐Pharmaceutical Firms
This study examines the termination of research alliances by established firms accessing knowledge from smaller research partners. We relax the assumption implicit in the internal tension perspective of alliance termination that signals from a partner are readily processed and acted upon. Instead, we consider that large firms involved in the alliance may have distributed decision‐making structures involving both alliance managers in charge of day‐to‐day activities and top managers who are responsible for a company’s strategic decision making. Using the information‐processing view of the firm we theorize on frictions as top managers evaluate the balance of tensions within the alliance. First, signals collected by units involved in the alliance must receive top management attention. Second, the accuracy and reliability with which signals are evaluated and acted upon is contingent on the composition of the top management team. An analysis of 235 alliances initiated by Top 50 pharmaceutical firms broadly supports our theoretical framework.
- 18 October 2021
- Published by Wiley in Journal of Management Studies
- Vol. 59 (5) , 1315-1353
The Role of Frictions due to Top Management in Alliance Termination Decisions: Insights from Established Bio‐Pharmaceutical Firms
This study examines the termination of research alliances by established firms accessing knowledge from smaller research partners. We relax the assumption implicit in the internal tension perspective of alliance termination that signals from a partner are readily processed and acted upon. Instead, we consider that large firms involved in the alliance may have distributed decision‐making structures involving both alliance managers in charge of day‐to‐day activities and top managers who are responsible for a company’s strategic decision making. Using the information‐processing view of the firm we theorize on frictions as top managers evaluate the balance of tensions within the alliance. First, signals collected by units involved in the alliance must receive top management attention. Second, the accuracy and reliability with which signals are evaluated and acted upon is contingent on the composition of the top management team. An analysis of 235 alliances initiated by Top 50 pharmaceutical firms broadly supports our theoretical framework.
- 1 March 2021
- Published by Institute for Operations Research and the Management Sciences (INFORMS) in Strategy Science
- Vol. 6 (1) , 62-74
Unbundling and Managing Uncertainty Surrounding Emerging Technologies
Emerging technologies, while offering enormous potential for economic growth, carry a high degree of uncertainty regarding whether and when that potential may be realized. How can firms evaluate the uncertainty surrounding an emerging technology? To address this question, we offer a structured approach that unbundles the uncertainty surrounding emerging technologies, incorporating both supply- and demand-side factors. These include the focal technology itself, the potential market applications, the users adopting the technology, the ecosystem of activities that support the technology’s value creation, and the business model with which the technology is being commercialized. We further consider that the uncertainty surrounding each of these sources may not be resolved in a vacuum, but, rather, that it may interact with other sources of uncertainty in a pooled, sequential, or reciprocal way. Such a structured approach of evaluating uncertainty can help firms and managers in terms of the cognitive processes and the managerial practices and provide microfoundations for dynamic managerial capabilities. We illustrate the applicability of the framework for two emerging technologies—gene therapy and autonomous vehicles—and how the framework can be integrated with prominent managerial practices for managing uncertainty.
- 1 March 2021
- Published by Institute for Operations Research and the Management Sciences (INFORMS) in Strategy Science
- Vol. 6 (1) , 62-74
Unbundling and Managing Uncertainty Surrounding Emerging Technologies
Emerging technologies, while offering enormous potential for economic growth, carry a high degree of uncertainty regarding whether and when that potential may be realized. How can firms evaluate the uncertainty surrounding an emerging technology? To address this question, we offer a structured approach that unbundles the uncertainty surrounding emerging technologies, incorporating both supply- and demand-side factors. These include the focal technology itself, the potential market applications, the users adopting the technology, the ecosystem of activities that support the technology’s value creation, and the business model with which the technology is being commercialized. We further consider that the uncertainty surrounding each of these sources may not be resolved in a vacuum, but, rather, that it may interact with other sources of uncertainty in a pooled, sequential, or reciprocal way. Such a structured approach of evaluating uncertainty can help firms and managers in terms of the cognitive processes and the managerial practices and provide microfoundations for dynamic managerial capabilities. We illustrate the applicability of the framework for two emerging technologies—gene therapy and autonomous vehicles—and how the framework can be integrated with prominent managerial practices for managing uncertainty.
- 1 July 2020
- Published by Institute for Operations Research and the Management Sciences (INFORMS) in Organization Science
- Vol. 31 (4) , 1012-1036
Competition, Technology Licensing-in, and Innovation
Although the relationship between competition and firm innovation has long been of scholarly interest, prior research has predominantly considered changes in internal research and development (R&D) as a strategic response to competitors’ actions. In this study, we focus on one of the most important and commonly observed contractual mechanisms used to acquire external technologies: technology licensing. Surprisingly, licensing has been mostly overlooked by prior studies examining the effect of competition on firms’ allocation of R&D. We take into account the unique properties of licensing and systematically link them to the demands arising from the competitive pressure caused by rivals’ launches of new products. Furthermore, we discuss how licensing-in decisions ultimately shape a firm’s subsequent innovation in areas where they are threatened by competitors and how such innovation depends on the cumulative R&D investments inside the organization into which licensed knowledge is added. We test our theoretical model through a longitudinal design that tracks the licensing-in and innovation outcomes of firms in the global biopharmaceutical industry. Accounting for the endogenous selection of firms into licensing, our findings illustrate that licensing-in is motivated by competitive pressures. We also find that licensing-in increases a firm’s capacity to innovate in areas where competitors have exerted pressure, particularly in the presence of cumulative R&D investments. In so doing, the paper anchors technology licensing as a key organizational action that helps increase our understanding of the important relationship between competition and innovation.
- 1 July 2020
- Published by Institute for Operations Research and the Management Sciences (INFORMS) in Organization Science
- Vol. 31 (4) , 1012-1036
Competition, Technology Licensing-in, and Innovation
Although the relationship between competition and firm innovation has long been of scholarly interest, prior research has predominantly considered changes in internal research and development (R&D) as a strategic response to competitors’ actions. In this study, we focus on one of the most important and commonly observed contractual mechanisms used to acquire external technologies: technology licensing. Surprisingly, licensing has been mostly overlooked by prior studies examining the effect of competition on firms’ allocation of R&D. We take into account the unique properties of licensing and systematically link them to the demands arising from the competitive pressure caused by rivals’ launches of new products. Furthermore, we discuss how licensing-in decisions ultimately shape a firm’s subsequent innovation in areas where they are threatened by competitors and how such innovation depends on the cumulative R&D investments inside the organization into which licensed knowledge is added. We test our theoretical model through a longitudinal design that tracks the licensing-in and innovation outcomes of firms in the global biopharmaceutical industry. Accounting for the endogenous selection of firms into licensing, our findings illustrate that licensing-in is motivated by competitive pressures. We also find that licensing-in increases a firm’s capacity to innovate in areas where competitors have exerted pressure, particularly in the presence of cumulative R&D investments. In so doing, the paper anchors technology licensing as a key organizational action that helps increase our understanding of the important relationship between competition and innovation.
- 26 January 2017
- Published by Wiley in Journal of Management Studies
- Vol. 54 (4) , 483-510
How Does Performance Feedback Affect Boundary Spanning in Multinational Corporations? Insights from Technology Scouts
As much as prior research has shed light on the boundary‐spanning processes of global organizations and their (positive) impact on an MNC's performance, whether, when and how past performance ultimately shapes an MNC's boundary‐spanning activities remains an open question in management research. To tackle these questions, we examine the behaviour of technology scouts in global organizations who span organizational and national boundaries to tap into novel knowledge and span internal boundaries to present this knowledge to constituents inside the MNC. Drawing on the behavioural theory of the firm, we propose that the intensity of organizational boundary spanning, the likelihood of spanning national boundaries and the way technology scouts span internal boundaries to engage with members inside the organization are sensitive to how the MNC has performed relative to its aspirations. We support our theoretical expositions with insights gained from interviewing senior industry professionals with direct experience in technology scouting in MNCs.
- 26 January 2017
- Published by Wiley in Journal of Management Studies
- Vol. 54 (4) , 483-510
How Does Performance Feedback Affect Boundary Spanning in Multinational Corporations? Insights from Technology Scouts
As much as prior research has shed light on the boundary‐spanning processes of global organizations and their (positive) impact on an MNC's performance, whether, when and how past performance ultimately shapes an MNC's boundary‐spanning activities remains an open question in management research. To tackle these questions, we examine the behaviour of technology scouts in global organizations who span organizational and national boundaries to tap into novel knowledge and span internal boundaries to present this knowledge to constituents inside the MNC. Drawing on the behavioural theory of the firm, we propose that the intensity of organizational boundary spanning, the likelihood of spanning national boundaries and the way technology scouts span internal boundaries to engage with members inside the organization are sensitive to how the MNC has performed relative to its aspirations. We support our theoretical expositions with insights gained from interviewing senior industry professionals with direct experience in technology scouting in MNCs.
- 1 January 2013
- Published by Elsevier in SSRN Electronic Journal
In Harsh - and Slack Times: How Does Firm Performance Affect the Intensity and the Direction of External Technology Sourcing?
Despite our understanding of the importance of external technology sourcing, we know little about what leads firms to become more open to sourcing external tech
- 1 January 2013
- Published by Elsevier in SSRN Electronic Journal
In Harsh - and Slack Times: How Does Firm Performance Affect the Intensity and the Direction of External Technology Sourcing?
Despite our understanding of the importance of external technology sourcing, we know little about what leads firms to become more open to sourcing external tech